Navigation Links
Lumetra Announces Sale of Subsidiary IntegriGuard
Date:9/30/2009

Sale Allows Healthcare Consulting Organization to Focus on Core Business

SAN FRANCISCO, Sept. 30 /PRNewswire/ -- Lumetra, the San Francisco-based healthcare solutions consulting organization, announced today the completion of the sale of its IntegriGuard subsidiary to HMS (Nasdaq: HMSY), a publicly traded company.

In making the announcement, Linda M. Sawyer, Ph.D., RN, Lumetra's Chief Executive Officer, stated: "The sale of IntegriGuard is a significant milestone in the implementation of our strategic plan and allows Lumetra to focus on our core business and clients, driving the advancement of healthcare through evidence-based solutions and technology."

IntegriGuard was formed in 1999 as a national division of Lumetra focusing on the prevention and detection of fraud and abuse in healthcare systems. It was established as a wholly-owned subsidiary in April 2003. The sale is effective immediately.

About Lumetra

Lumetra provides reliable professional services and sustainable solutions through integrated clinical, technological, and analytic expertise to transform the delivery and administration of healthcare. For more information, please visit www.lumetra.com.

SOURCE Lumetra


'/>"/>
SOURCE Lumetra
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Lumetra Program Improves Diabetes Care Among Latinos
2. UCSF Announces Expanded BreastCancerTrials.org Website
3. DSS Research Announces Senior Health Risk Assessment (SrHRA)(TM)
4. US Farms, Inc. Announces Distribution Partnership With Natures Best
5. Datafarm™ Announces HollisterStier Contract Manufacturing Regulatory Affairs Deploys S-Cubed eCTD
6. Hutchinson Metro Center Announces Over 50,000 SF in New Leases for Medical Space at Bronx Complex
7. President Announces Free Health Plan
8. NovoCure Ltd. announces closing of financing round
9. RCRC Independent Review Board Announces DHHS Research Oversight
10. change:healthcare Announces Twitter Application that brings Healthcare Information and Costs to Consumers' Fingertips
11. QRxPharma Announces Strategic Alliance with Liaoning Nuokang Medicines Co Ltd for the Development of Venomics Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... ... agency which serves Lawrenceville, New Jersey and the surrounding area, is inaugurating ... lateral sclerosis (ALS), more commonly known as Lou Gehrig's disease or motor neurone ...
(Date:1/19/2017)... , ... January 18, 2017 , ... The CHP suggests ... during a rain storm by slowing down and increasing the space between themselves and ... Los Angeles based car accident attorney Raymond R. Hassanlou notes that, rain or shine, ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... styled text designs that will simplify the editing process for all media productions," ... Basics is a package of 30 simplistically styled self-animating paragraphs designed for multi-lined ...
(Date:1/18/2017)... Austin, TX (PRWEB) , ... January 18, 2017 , ... ... million people opened a global discussion about the benefits of fidgeting to relieve stress ... Lyon and Jym Daniel. Their Think Ink Pen had just completed a successful ...
(Date:1/18/2017)... SAN JOSE, Calif, USA; and SHANGHAI, China – , ... ... January 18, 2017 -- Global public health organization NSF International ... V (pentavalent arsenic) to NSF/ANSI 53: Drinking Water Treatment Units ... treatment units. This certification verifies that MicroCeramics’ NanoNose Pitcher Filter ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 2017  EnteroMedics Inc. (NASDAQ: ETRM ... technology to treat obesity, metabolic diseases and other ... underwritten public offering of units for gross proceeds ... and commissions and offering expenses payable by EnteroMedics. ... A Units, priced at a public offering price ...
(Date:1/18/2017)...  Adaptive Sound Technologies, Inc. (ASTI), the leading supplier ... Hyatt Place Nashville/Downtown to deliver the best sleep experience ... machines in over two hundred of its guest rooms. ... of having a great stay is sleeping well," said ... Nashville/Downtown. "We,re pleased to be able to offer our ...
(Date:1/18/2017)... 18, 2017  Dermata Therapeutics, LLC, a biotechnology ... a variety of dermatological diseases, announces dosing the ... a Phase 2 acne rosacea study. DMT210 is ... proinflammatory cytokines in the skin responsible for the ... This clinical trial, DMT210-003, is a ...
Breaking Medicine Technology: